Letter to the editor: Short‐term data on machine perfusion should be extrapolated with caution
Dev Katarey – 8 October 2021
DDX17‐regulated alternative splicing that produced an oncogenic isoform of PXN‐AS1 to promote HCC metastasis
Hong‐Zhong Zhou, Fan Li, Sheng‐Tao Cheng, Yong Xu, Hai‐Jun Deng, Da‐Yong Gu, Jin Wang, Wei‐Xian Chen, Yu‐Jiao Zhou, Min‐Li Yang, Ji‐Hua Ren, Lu Zheng, Ai‐Long Huang, Juan Chen – 8 October 2021
Reply
Femke H.C. Goeij, Andrea Schlegel, Philipp Dutkowski – 7 October 2021
A Meta‐Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients
Jieling Xiao, Jie Ning Yong, Cheng Han Ng, Nicholas Syn, Wen Hui Lim, Darren Jun Hao Tan, En Ying Tan, Daniel Huang, Raymond C. Wong, Nicholas W. S. Chew, Eunice Xiang Xuan Tan, Mazen Noureddin, Mohammad Shadab Siddiqui, Mark D. Muthiah – 7 October 2021 – The shift in the changing etiology of cirrhosis requiring liver transplantation (LT) has resulted in an increasing prevalence of coronary artery disease (CAD) that can potentially impact post‐LT outcomes.
Turning the Tide on Hepatitis C Virus–Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand
Jess Howell, Avik Majumdar, Michael A. Fink, Mandy Byrne, Geoff McCaughan, Simone I. Strasser, Michael Crawford, Peter Hodgkinson, Katherine A. Stuart, Caroline Tallis, John Chen, Alan Wigg, Robert Jones, Bryon Jaques, Gary Jeffrey, Leon Adams, Michael C. Wallace, Stephen Munn, Ed Gane, Alex J.
Macrophage nuclear factor erythroid 2‐related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3–mediated RhoA/ROCK pathway in the ischemic liver
Jianhua Rao, Jiannan Qiu, Ming Ni, Hao Wang, Peng Wang, Lei Zhang, Zeng Wang, Mu Liu, Feng Cheng, Xuehao Wang, Ling Lu – 7 October 2021
Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay
Vinay Sundaram, Rajiv Jalan – 7 October 2021
Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study
Lanlan Chen, Hongqun Yang, Haitao Li, Chang He, Liu Yang, Guoyue Lv – 7 October 2021
Reply
Alberto Calleri, Margherita Saracco, Fabrizia Pittaluga, Rossana Cavallo, Renato Romagnoli, Silvia Martini – 6 October 2021
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
Amit G. Singal, Nabihah Tayob, Anand Mehta, Jorge A. Marrero, Hashem El‐Serag, Qingchun Jin, Cristian Saenz de Viteri, Austin Fobar, Neehar D. Parikh – 6 October 2021